Real-world experiences and treatment patterns among congenital heart disease patients with associated pulmonary vascular disease: Results from a real-world survey in the United States

Background: Limited data exist on the use of drugs in patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). Therefore, we evaluated their real-world patient journey, including symptomatology, diagnostic pathway, treatment patterns, and guideline adherence....

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Jordan D. Awerbach, MD, MPH, Carly J. Paoli, PharmD, MPH, Megan Scott, BSc, Gurinderpal Doad, PharmD, Julia Harley, BSc, Daniel Graham, MSc, Mark Small, BSc, Sumeet Panjabi, PhD, Leigh C. Reardon, MD, FACC
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-08-01
Rangatū:	JHLT Open
Ngā marau:	Pulmonary arterial hypertension Congenital heart disease Pulmonary vascular disease Fontan circulation Treatment patterns Real-world evidence
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2950133425001211
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!